Roche Holding AG (RHHBF)
Roche Statistics
Share Statistics
Roche has 754.24M shares outstanding. The number of shares has increased by 3.39% in one year.
| Shares Outstanding | 754.24M |
| Shares Change (YoY) | 3.39% |
| Shares Change (QoQ) | 0.28% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 205.09M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 26.33 and the forward PE ratio is null. Roche's PEG ratio is -0.96.
| PE Ratio | 26.33 |
| Forward PE | n/a |
| PS Ratio | 3.49 |
| Forward PS | n/a |
| PB Ratio | 6.86 |
| P/FCF Ratio | 14.44 |
| PEG Ratio | -0.96 |
Enterprise Valuation
Roche has an Enterprise Value (EV) of 247.27B.
| EV / Sales | 3.96 |
| EV / EBITDA | 14.88 |
| EV / EBIT | 12.31 |
| EV / FCF | 16.39 |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 1.14.
| Current Ratio | 1.48 |
| Quick Ratio | 1.2 |
| Debt / Equity | 1.14 |
| Debt / EBITDA | 2.19 |
| Debt / FCF | 2.41 |
| Interest Coverage | 9.56 |
Financial Efficiency
Return on Equity is 26.06% and Return on Invested Capital is 13.22%.
| Return on Equity | 26.06% |
| Return on Assets | 8.13% |
| Return on Invested Capital | 13.22% |
| Revenue Per Employee | $604.32K |
| Profits Per Employee | $80.17K |
| Employee Count | 103,249 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 2.14 |
Taxes
| Income Tax | 2.61B |
| Effective Tax Rate | 22.1% |
Stock Price Statistics
The stock price has increased by 40.78% in the last 52 weeks. The beta is 0.22, so Roche's price volatility has been higher than the market average.
| Beta | 0.22 |
| 52-Week Price Change | 40.78% |
| 50-Day Moving Average | 349.9 |
| 200-Day Moving Average | 333.99 |
| Relative Strength Index (RSI) | 56.8 |
| Average Volume (20 Days) | 142 |
Income Statement
In the last 12 months, Roche had revenue of 62.4B and earned 8.28B in profits. Earnings per share was 10.39.
| Revenue | 62.4B |
| Gross Profit | 46.11B |
| Operating Income | 13.42B |
| Net Income | 8.28B |
| EBITDA | 16.62B |
| EBIT | 13.2B |
| Earnings Per Share (EPS) | 10.39 |
Balance Sheet
The company has 6.97B in cash and 36.35B in debt, giving a net cash position of -29.38B.
| Cash & Cash Equivalents | 6.97B |
| Total Debt | 36.35B |
| Net Cash | -29.38B |
| Retained Earnings | 43.84B |
| Total Assets | 101.8B |
| Working Capital | 13.01B |
Cash Flow
In the last 12 months, operating cash flow was 20.09B and capital expenditures -5.01B, giving a free cash flow of 15.09B.
| Operating Cash Flow | 20.09B |
| Capital Expenditures | -5.01B |
| Free Cash Flow | 15.09B |
| FCF Per Share | 18.93 |
Margins
Gross margin is 73.9%, with operating and profit margins of 21.5% and 13.27%.
| Gross Margin | 73.9% |
| Operating Margin | 21.5% |
| Pretax Margin | 18.9% |
| Profit Margin | 13.27% |
| EBITDA Margin | 26.64% |
| EBIT Margin | 21.5% |
| FCF Margin | 24.18% |
Dividends & Yields
RHHBF pays an annual dividend of $10.97, which amounts to a dividend yield of 3.14%.
| Dividend Per Share | $10.97 |
| Dividend Yield | 3.14% |
| Dividend Growth (YoY) | 0.45% |
| Payout Ratio | 88.43% |
| Earnings Yield | 3.8% |
| FCF Yield | 6.92% |
Analyst Forecast
Currently there are no analyst rating for RHHBF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 5.01 |
| Piotroski F-Score | 7 |